Evidence of lipid peroxidation in patients taking neuroleptic drugs

Gianluigi Vendemiale, Piero Portincasa, Giuseppe Palasciano, Emanuele Altomare

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This study investigated the effect of chronic neuroleptic therapy on hepatic glutathione concentration in relation to lipid peroxidation. Hepatic malondialdehyde (MDA) and glutathione (GSH) concentrations were measured in liver biopsies from a group of patients receiving chronic psychotropic drug therapy. The results were compared with values obtained from a selected group of controls and correlated to liver histology and blood biochemistry. Patients taking neuroleptics exhibited increased hepatic MDA and decreased total GSH levels when compared with controls. The reduction of GSH was accompanied by a 25% increase in oxidized glutathione (GSSG) concentrations. In addition, a positive correlation between liver MDA and GSSG concentrations was observed in the group receiving neuroleptic therapy. The study results suggest that an increased lipid peroxidation may represent a contributory mechanism for neuroleptic drug toxicity.

Original languageEnglish
Pages (from-to)133-141
Number of pages9
JournalCurrent Therapeutic Research
Volume55
Issue number2
DOIs
Publication statusPublished - 1994

Fingerprint

Lipid Peroxidation
Antipsychotic Agents
Glutathione Disulfide
Liver
Malondialdehyde
Glutathione
Psychotropic Drugs
Drug-Related Side Effects and Adverse Reactions
Biochemistry
Histology
Biopsy
Drug Therapy
Control Groups
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Evidence of lipid peroxidation in patients taking neuroleptic drugs. / Vendemiale, Gianluigi; Portincasa, Piero; Palasciano, Giuseppe; Altomare, Emanuele.

In: Current Therapeutic Research, Vol. 55, No. 2, 1994, p. 133-141.

Research output: Contribution to journalArticle

Vendemiale, G, Portincasa, P, Palasciano, G & Altomare, E 1994, 'Evidence of lipid peroxidation in patients taking neuroleptic drugs', Current Therapeutic Research, vol. 55, no. 2, pp. 133-141. https://doi.org/10.1016/S0011-393X(05)80685-X
Vendemiale, Gianluigi ; Portincasa, Piero ; Palasciano, Giuseppe ; Altomare, Emanuele. / Evidence of lipid peroxidation in patients taking neuroleptic drugs. In: Current Therapeutic Research. 1994 ; Vol. 55, No. 2. pp. 133-141.
@article{9ee3ff00a2fc4d4bad4fcb47a235c816,
title = "Evidence of lipid peroxidation in patients taking neuroleptic drugs",
abstract = "This study investigated the effect of chronic neuroleptic therapy on hepatic glutathione concentration in relation to lipid peroxidation. Hepatic malondialdehyde (MDA) and glutathione (GSH) concentrations were measured in liver biopsies from a group of patients receiving chronic psychotropic drug therapy. The results were compared with values obtained from a selected group of controls and correlated to liver histology and blood biochemistry. Patients taking neuroleptics exhibited increased hepatic MDA and decreased total GSH levels when compared with controls. The reduction of GSH was accompanied by a 25{\%} increase in oxidized glutathione (GSSG) concentrations. In addition, a positive correlation between liver MDA and GSSG concentrations was observed in the group receiving neuroleptic therapy. The study results suggest that an increased lipid peroxidation may represent a contributory mechanism for neuroleptic drug toxicity.",
author = "Gianluigi Vendemiale and Piero Portincasa and Giuseppe Palasciano and Emanuele Altomare",
year = "1994",
doi = "10.1016/S0011-393X(05)80685-X",
language = "English",
volume = "55",
pages = "133--141",
journal = "Current Therapeutic Research - Clinical and Experimental",
issn = "0011-393X",
publisher = "Excerpta Medica",
number = "2",

}

TY - JOUR

T1 - Evidence of lipid peroxidation in patients taking neuroleptic drugs

AU - Vendemiale, Gianluigi

AU - Portincasa, Piero

AU - Palasciano, Giuseppe

AU - Altomare, Emanuele

PY - 1994

Y1 - 1994

N2 - This study investigated the effect of chronic neuroleptic therapy on hepatic glutathione concentration in relation to lipid peroxidation. Hepatic malondialdehyde (MDA) and glutathione (GSH) concentrations were measured in liver biopsies from a group of patients receiving chronic psychotropic drug therapy. The results were compared with values obtained from a selected group of controls and correlated to liver histology and blood biochemistry. Patients taking neuroleptics exhibited increased hepatic MDA and decreased total GSH levels when compared with controls. The reduction of GSH was accompanied by a 25% increase in oxidized glutathione (GSSG) concentrations. In addition, a positive correlation between liver MDA and GSSG concentrations was observed in the group receiving neuroleptic therapy. The study results suggest that an increased lipid peroxidation may represent a contributory mechanism for neuroleptic drug toxicity.

AB - This study investigated the effect of chronic neuroleptic therapy on hepatic glutathione concentration in relation to lipid peroxidation. Hepatic malondialdehyde (MDA) and glutathione (GSH) concentrations were measured in liver biopsies from a group of patients receiving chronic psychotropic drug therapy. The results were compared with values obtained from a selected group of controls and correlated to liver histology and blood biochemistry. Patients taking neuroleptics exhibited increased hepatic MDA and decreased total GSH levels when compared with controls. The reduction of GSH was accompanied by a 25% increase in oxidized glutathione (GSSG) concentrations. In addition, a positive correlation between liver MDA and GSSG concentrations was observed in the group receiving neuroleptic therapy. The study results suggest that an increased lipid peroxidation may represent a contributory mechanism for neuroleptic drug toxicity.

UR - http://www.scopus.com/inward/record.url?scp=0028355319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028355319&partnerID=8YFLogxK

U2 - 10.1016/S0011-393X(05)80685-X

DO - 10.1016/S0011-393X(05)80685-X

M3 - Article

AN - SCOPUS:0028355319

VL - 55

SP - 133

EP - 141

JO - Current Therapeutic Research - Clinical and Experimental

JF - Current Therapeutic Research - Clinical and Experimental

SN - 0011-393X

IS - 2

ER -